{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T19:35:35Z","timestamp":1754163335786,"version":"3.41.2"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T00:00:00Z","timestamp":1750636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T00:00:00Z","timestamp":1750636800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>To explore travel burden in patients with self-reported curable and incurable cancer.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Method<\/jats:title>\n            <jats:p>A 2-day flash mob study was conducted in March 2023 among patients visiting medical oncology departments in 65 Dutch hospitals. Disease status was self-reported. Patients completed a questionnaire on travel time (one-way), travel problems, and willingness to travel. Descriptive analyses and logistic regression analyses were used to assess travel burden and its associated factors.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>In total, 991 patients with curable and 1959 with incurable cancer were included. Patients with curable cancer more often reported daily or weekly hospital visits (63% vs. 22%, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) and a travel time of less than 30\u00a0min (78% vs. 73%, <jats:italic>p<\/jats:italic>\u2009=\u20090.005). Almost one-third of patients with curable (28%) and incurable cancer (29%) experienced some travel problems. Patients with worse physical functioning and longer travel times were more likely to experience travel problems. Disease status was not associated with experiencing travel problems or the willingness to travel for oncological care. Instead, willingness to travel was associated with patients\u2019 level of education, physical functioning, and tumour type.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Being diagnosed with self-reported curable or incurable cancer was not associated with experiencing travel problems or the willingness to travel for oncological care. Experiencing travel problems was associated with physical functioning and travel time, and the willingness to travel was associated with level of education, physical functioning, and tumour type. To ensure accessible and patient-centred care, physicians should be aware of these potential barriers and aim to provide well-coordinated, personalised care close to home.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s00520-025-09675-4","type":"journal-article","created":{"date-parts":[[2025,6,22]],"date-time":"2025-06-22T19:30:21Z","timestamp":1750620621000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Differences in travel burden between patients with self-reported curable and incurable cancer: results from a Dutch flash mob study"],"prefix":"10.1007","volume":"33","author":[{"given":"M. A. J.","family":"Versluis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. C. S.","family":"de Boer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. V.","family":"van de Poll-Franse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. J. H.","family":"Raijmakers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. A. J.","family":"Vissers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I. H.","family":"Dingemans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. B.","family":"de Ruiter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Slingerland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. K. L.","family":"Reyners","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. E. T.","family":"Tesselaar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. N. M.","family":"Wymenga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,23]]},"reference":[{"key":"9675_CR1","unstructured":"Centraal Bureau van Statistiek (CBS) (2024) Overleden; belangrijke doodsoorzaken (korte lijst), leeftijd, geslacht. https:\/\/opendata.cbs.nl\/statline\/#\/CBS\/nl\/dataset\/7052_95\/table?fromstatweb. Accessed 15 Jan 2025"},{"key":"9675_CR2","unstructured":"Nederlandse Kanker Registratie (NKR) (2022) NKR viewer. https:\/\/NKRnkr-cijfers.iknl.nl\/viewer\/incidentie-per-jaar?language=nl_NL&viewerId=37bbe26d-252f-46d5\u20139495-ab13b5f098e6. Accessed 15 Jan 2025"},{"issue":"2","key":"9675_CR3","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.ejso.2021.07.023","volume":"48","author":"JCHBM Luijten","year":"2022","unstructured":"Luijten JCHBM, Nieuwenhuijzen GAP, Sosef MN, de Hingh IHJT, Rosman C, Ruurda JP, van Duijvendijk P, Heisterkamp J, de Steur WO, van Laarhoven HWM, Besselink MG, Groot Koerkamp B, van Santvoort HC, Lemmens VEP, Vissers PAJ (2022) Impact of nationwide centralization of oesophageal, gastric, and pancreatic surgery on travel distance and experienced burden in the Netherlands. Eur J Surg Oncol 48(2):348\u2013355. https:\/\/doi.org\/10.1016\/j.ejso.2021.07.023","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"9675_CR4","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1177\/0825859721989524","volume":"37","author":"J Van Roij","year":"2022","unstructured":"Van Roij J, de Zeeuw B, Zijlstra M, Claessens N, Raijmakers N, van de Poll-Franse L, Brom L (2022) Shared perspectives of patients with advanced cancer and their informal caregivers on essential aspects of health care: a qualitative study. J Palliat Care 37(3):372\u2013380. https:\/\/doi.org\/10.1177\/0825859721989524","journal-title":"J Palliat Care"},{"issue":"6","key":"9675_CR5","doi-asserted-by":"publisher","first-page":"5381","DOI":"10.1007\/s00520-022-06978-8","volume":"30","author":"DS Stoyanov","year":"2022","unstructured":"Stoyanov DS, Conev NV, Donev IS, Tonev ID, Panayotova TV, Dimitrova-Gospodinova EG (2022) Impact of travel burden on clinical outcomes in lung cancer. Support Care Cancer 30(6):5381\u20135387. https:\/\/doi.org\/10.1007\/s00520-022-06978-8","journal-title":"Support Care Cancer"},{"key":"9675_CR6","doi-asserted-by":"publisher","unstructured":"de Almeida RJ, de Moraes Luizaga CT, Eluf-Neto J, de Carvalho Nunes HR, Pessoa EC, Murta-Nascimento C (2022) Impact of educational level and travel burden on breast cancer stage at diagnosis in the state of Sao Paulo, Brazil. Sci Rep 19;12(1):8357 https:\/\/doi.org\/10.1038\/s41598-022-12487-9","DOI":"10.1038\/s41598-022-12487-9"},{"issue":"12","key":"9675_CR7","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1634\/theoncologist.2015-0110","volume":"20","author":"M Ambroggi","year":"2015","unstructured":"Ambroggi M, Biasini C, Del Giovane C, Fornari F, Cavanna L (2015) Distance as a barrier to cancer diagnosis and treatment: review of the literature. Oncologist 20(12):1378\u20131385. https:\/\/doi.org\/10.1634\/theoncologist.2015-0110","journal-title":"Oncologist"},{"issue":"6","key":"9675_CR8","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1111\/j.1440-1584.2011.01232.x","volume":"19","author":"A Zucca","year":"2011","unstructured":"Zucca A, Boyes A, Newling G, Hall A, Girgis A (2011) Travelling all over the countryside: travel-related burden and financial difficulties reported by cancer patients in New South Wales and Victoria. Aust J Rural Health 19(6):298\u2013305. https:\/\/doi.org\/10.1111\/j.1440-1584.2011.01232.x","journal-title":"Aust J Rural Health"},{"key":"9675_CR9","unstructured":"Centraal Bureau voor de Statistiek (CBS) (2024) Bevolking, kerncijfers. https:\/\/www.cbs.nl\/nl-nl\/cijfers\/detail\/85496NED?q=bevolkingsdichtheid Accessed 15 Jan 2025"},{"key":"9675_CR10","first-page":"D7989","volume":"167","author":"ECS De Boer","year":"2023","unstructured":"De Boer ECS, Versluis MAJ, Vissers PAJ, Slingerland M, Haberkorn BCM, de Ruiter MB, Dingemans IH, van de Poll-Franse LV, Reyners AKL, Wymenga ANM (2023) How long are medical oncology patients in The Netherlands willing to travel for their cancer care? Ned Tijdschr Geneesk 167:D7989 (Dutch only)","journal-title":"Ned Tijdschr Geneesk"},{"issue":"14","key":"9675_CR11","doi-asserted-by":"publisher","first-page":"2188e94","DOI":"10.1016\/j.ejca.2011.04.034","volume":"47","author":"LV Van de Poll-Franse","year":"2011","unstructured":"Van de Poll-Franse LV, Horevoorts N, van Eenbergen M, Denollet J, Roukema J, Aaronson NK, Vingerhoets A, Coebergh J, de Vries J, Essink-Bot M, Mols F, Profiles Registry Group (2011) The patient reported outcomes following initial treatment and long term evaluation of survivorship registry: scope, rationale and design of an infrastructure for the study of physical and psychosocial outcomes in cancer survivorship cohorts. Eur J Cancer 47(14):2188e94. https:\/\/doi.org\/10.1016\/j.ejca.2011.04.034","journal-title":"Eur J Cancer"},{"issue":"5","key":"9675_CR12","doi-asserted-by":"publisher","first-page":"365e76","DOI":"10.1093\/jnci\/85.5.365","volume":"85","author":"NK Aaronson","year":"1993","unstructured":"Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85(5):365e76. https:\/\/doi.org\/10.1093\/jnci\/85.5.365","journal-title":"J Natl Cancer Inst"},{"issue":"13e14","key":"9675_CR13","doi-asserted-by":"publisher","first-page":"2260e3","DOI":"10.1016\/0959-8049(95)00296-0","volume":"31A","author":"S Kaasa","year":"1995","unstructured":"Kaasa S, Bjordal K, Aaronson N, Moum T, Wist E, Hagen S, Kvikstad A (1995) The EORTC core quality of life questionnaire (QLQ-C30): validated and reliability when analysed with patients treated with palliative radiotherapy. Eur J Cancer 31A(13e14):2260e3. https:\/\/doi.org\/10.1016\/0959-8049(95)00296-0","journal-title":"Eur J Cancer"},{"issue":"1","key":"9675_CR14","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1097\/00005650-200301000-00013","volume":"41","author":"N Cousineau","year":"2003","unstructured":"Cousineau N, McDowel I, Hotz S, Hebert P (2003) Measuring chronic patients\u2019 feelings of being a burden to their caregivers: development and preliminary validation of a scale. Med Care 41(1):110\u2013118. https:\/\/doi.org\/10.1097\/00005650-200301000-00013","journal-title":"Med Care"},{"issue":"2","key":"9675_CR15","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.socscimed.2006.09.013","volume":"64","author":"CJ McPherson","year":"2007","unstructured":"McPherson CJ, Wilson KG, Murray MA (2007) Feeling like a burden: exploring the perspectives of patients at the end of life. Soc Sci Med 64(2):417\u2013427. https:\/\/doi.org\/10.1016\/j.socscimed.2006.09.013","journal-title":"Soc Sci Med"},{"key":"9675_CR16","unstructured":"Nederlandse federatie van kankerpati\u00ebntenorganisaties (NFK) (2019) Wordt het vervoer van en naar mijn ziekenhuis vergoed? www.nfk.nl\/actueel\/nieuws\/wordt-het-vervoer-van-en-naar-mijn-ziekenhuis-vergoed#:~:text=Voor%20kankerpati\u00ebnten%20geldt%20dat%20de,immuuntherapie%20of%20radiotherapie%20moet%20ondergaan. Accessed 15 Jan 2025"},{"issue":"1","key":"9675_CR17","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1186\/s13023-021-01886-2","volume":"16","author":"E De Heus","year":"2021","unstructured":"De Heus E, Engelen V, Dingemans I, Richel C, Schrieks M, van der Zwan J, Besselink MG, van Berge Henegouwen MI, van Herpen CML, Duijts SFA (2021) Differences in health care experiences between rare cancer and common cancer patients: results from a national cross-sectional survey. Orphanet J Rare Dis 16(1):249. https:\/\/doi.org\/10.1186\/s13023-021-01886-2","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"9675_CR18","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1007\/s11764-018-0708-6","volume":"12","author":"H G\u00f6tze","year":"2018","unstructured":"G\u00f6tze H, Taubenheim S, Dietz A, Lordick F, Mehnert A (2018) Comorbid conditions and health-related quality of life in long-term cancer survivors\u2014associations with demographic and medical characteristics. J Cancer Surviv 12(5):712\u2013720. https:\/\/doi.org\/10.1007\/s11764-018-0708-6","journal-title":"J Cancer Surviv"},{"key":"9675_CR19","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.ejca.2022.01.039","volume":"165","author":"J Van Roij","year":"2022","unstructured":"Van Roij J, Raijmakers N, Ham L, van den Beuken-Everdingen M, van den Borne B, Creemers G, Hunting JC, Kuip E, van Leeuwen L, van Laarhoven H, Mandigers C, Nieboer P, van der Velden L, van Zuylen L, Gelissen J, Zijlstra M, Brom L, Fransen HP, van de Poll-Fransen L, eQuiPe study group (2022) Quality of life and quality of care as experienced by patients with advanced cancer and their relatives: a multicentre observational cohort study (eQuiPe). Eur J Cancer 165:125\u2013135. https:\/\/doi.org\/10.1016\/j.ejca.2022.01.039","journal-title":"Eur J Cancer"},{"key":"9675_CR20","unstructured":"Centraal Bureau voor de Statistiek (CBS) (2024) Nederlanders hebben steeds vaker hbo of universiteit gevolgd. https:\/\/www.cbs.nl\/nl-nl\/nieuws\/2024\/41\/nederlanders-hebben-steeds-vaker-hbo-of-universiteit-gevolgd Accessed 15 Jan 2025"},{"key":"9675_CR21","unstructured":"Nederlandse Kanker Registratie (NKR) (2023) NKR viewer: prevalentie. https:\/\/nkr-cijfers.iknl.nl\/viewer\/prevalentie-per-jaar?language=nl_NL&viewerId=dbf381bc-aae0-41f8-bf31-239be0d7e567 Accessed 15 Jan 2025"},{"issue":"4","key":"9675_CR22","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1504\/ijbhr.2011.043414","volume":"2","author":"R Rosenman","year":"2011","unstructured":"Rosenman R, Tennekoon V, Hill LG (2011) Measuring bias in self-reported data. Int J Behav Healthc Res 2(4):320\u2013332. https:\/\/doi.org\/10.1504\/ijbhr.2011.043414","journal-title":"Int J Behav Healthc Res"},{"issue":"9","key":"9675_CR23","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1002\/pon.5704","volume":"30","author":"M Loucka","year":"2021","unstructured":"Loucka M, Vlckova K, Tuckova A, Polakova K, Houska A, Mateju M, Donatova Z (2021) Prognostic awareness in advanced cancer patients and their caregivers: a longitudinal cohort study. Psychooncology 30(9):1449\u20131456. https:\/\/doi.org\/10.1002\/pon.5704","journal-title":"Psychooncology"},{"issue":"2","key":"9675_CR24","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1177\/02692163241301220","volume":"39","author":"MAJ Versluis","year":"2025","unstructured":"Versluis MAJ, van de Poll-Franse LV, Zijlstra M, van Laarhoven HWM, Vreugdenhil G, Henselmans I, Brom L, Kuip EJM, van der Linden YM, Raijmakers NHJ (2025) Changes in perception of prognosis in the last year of life of patients with advanced cancer and its associated factors: longitudinal results of the eQuiPe study. Palliat Med 39(2):277\u2013285. https:\/\/doi.org\/10.1177\/02692163241301220","journal-title":"Palliat Med"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-09675-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-025-09675-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-09675-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T04:07:17Z","timestamp":1753934837000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-025-09675-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,23]]},"references-count":24,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["9675"],"URL":"https:\/\/doi.org\/10.1007\/s00520-025-09675-4","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"type":"print","value":"0941-4355"},{"type":"electronic","value":"1433-7339"}],"subject":[],"published":{"date-parts":[[2025,6,23]]},"assertion":[{"value":"5 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This is an observational study. The medical ethics review board of the University Medical Centre Groningen has declared that no ethical approval is required for conducting this research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Patients were informed about the study aim, and completing the questionnaire was considered as giving consent to use their information for this research purpose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"610"}}